|
PLA2G12A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.45029999962543E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.53759999960346E-07 |
| Normal-vs-Stage2 |
2.090600E-01 |
| Normal-vs-Stage3 |
4.593400E-04 |
| Normal-vs-Stage4 |
5.987600E-01 |
| Stage1-vs-Stage2 |
1.604850E-01 |
| Stage1-vs-Stage3 |
2.762400E-01 |
| Stage1-vs-Stage4 |
4.356800E-01 |
| Stage2-vs-Stage3 |
8.746000E-02 |
| Stage2-vs-Stage4 |
8.961400E-01 |
| Stage3-vs-Stage4 |
1.761990E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.16750000006749E-07 |
| Normal-vs-AfricanAmerican |
1.710310E-02 |
| Normal-vs-Asian |
4.386800E-01 |
| Caucasian-vs-AfricanAmerican |
1.959750E-01 |
| Caucasian-vs-Asian |
9.570400E-01 |
| AfricanAmerican-vs-Asian |
6.434600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62690000027332E-07 |
| Normal-vs-Female |
5.036000E-03 |
| Male-vs-Female |
3.009400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.800800E-03 |
| Normal-vs-Extreme_Weight |
4.52979999998604E-06 |
| Normal-vs-Obese |
1.560480E-04 |
| Normal-vs-Extreme_Obese |
4.919200E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.917400E-01 |
| Normal_Weight-vs-Obese |
9.271600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.264000E-01 |
| Extreme_Weight-vs-Obese |
5.832800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.903220E-01 |
| Obese-vs-Extreme_Obese |
2.630200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.472200E-01 |
| Normal-vs-Age(41-60Yrs) |
9.173500E-04 |
| Normal-vs-Age(61-80Yrs) |
3.03299999560025E-08 |
| Normal-vs-Age(81-100Yrs) |
4.957800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.791600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.180420E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.576600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.309900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.070400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.545800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62349999999201E-05 |
| Normal-VS-Type2 PRCC |
8.91290000026856E-07 |
| Normal-VS-KIRP CIMP |
9.115600E-01 |
| Normal-VS-Unclassified PRCC |
6.896200E-03 |
| Type1 PRCC-VS-Type2 PRCC |
5.120200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.333600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.920200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.290200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.739970E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.670800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.588500E-04 |
| Normal-vs-N1 |
1.734100E-02 |
| Normal-vs-N2 |
6.005000E-01 |
| N0-vs-N1 |
7.797400E-01 |
| N0-vs-N2 |
5.247400E-01 |
| N1-vs-N2 |
5.536800E-01 |
|
|
